Your browser doesn't support javascript.
loading
Profound Treg perturbations correlate with COVID-19 severity.
Galván-Peña, Silvia; Leon, Juliette; Chowdhary, Kaitavjeet; Michelson, Daniel A; Vijaykumar, Brinda; Yang, Liang; Magnuson, Angela M; Chen, Felicia; Manickas-Hill, Zachary; Piechocka-Trocha, Alicja; Worrall, Daniel P; Hall, Kathryn E; Ghebremichael, Musie; Walker, Bruce D; Li, Jonathan Z; Yu, Xu G; Mathis, Diane; Benoist, Christophe.
Afiliação
  • Galván-Peña S; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Leon J; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Chowdhary K; Imagine Institute, INSERM UMR 1163, University of Paris, 75015 Paris, France.
  • Michelson DA; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Vijaykumar B; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Yang L; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Magnuson AM; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Chen F; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Manickas-Hill Z; Department of Immunology, Harvard Medical School, Boston, MA 02115.
  • Piechocka-Trocha A; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115.
  • Worrall DP; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
  • Hall KE; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115.
  • Ghebremichael M; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
  • Walker BD; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115.
  • Li JZ; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
  • Yu XG; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115.
  • Mathis D; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115.
  • Benoist C; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
Proc Natl Acad Sci U S A ; 118(37)2021 09 14.
Article em En | MEDLINE | ID: mdl-34433692
ABSTRACT
The hallmark of severe COVID-19 is an uncontrolled inflammatory response, resulting from poorly understood immunological dysfunction. We hypothesized that perturbations in FoxP3+ T regulatory cells (Treg), key enforcers of immune homeostasis, contribute to COVID-19 pathology. Cytometric and transcriptomic profiling revealed a distinct Treg phenotype in severe COVID-19 patients, with an increase in Treg proportions and intracellular levels of the lineage-defining transcription factor FoxP3, correlating with poor outcomes. These Tregs showed a distinct transcriptional signature, with overexpression of several suppressive effectors, but also proinflammatory molecules like interleukin (IL)-32, and a striking similarity to tumor-infiltrating Tregs that suppress antitumor responses. Most marked during acute severe disease, these traits persisted somewhat in convalescent patients. A screen for candidate agents revealed that IL-6 and IL-18 may individually contribute different facets of these COVID-19-linked perturbations. These results suggest that Tregs may play nefarious roles in COVID-19, by suppressing antiviral T cell responses during the severe phase of the disease, and by a direct proinflammatory role.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / COVID-19 Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / COVID-19 Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article